Avricore Health Inc. (TSXV:AVCR)

Avricore Health Statistics

Total Valuation

Avricore Health has a market cap or net worth of CAD 7.09 million. The enterprise value is 6.55 million.

Market Cap	7.09M
Enterprise Value	6.55M

Important Dates

The next estimated earnings date is Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Avricore Health has 101.29 million shares outstanding. The number of shares has decreased by -2.09% in one year.

Current Share Class	101.29M
Shares Outstanding	101.29M
Shares Change (YoY)	-2.09%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.60%
Owned by Institutions (%)	n/a
Float	92.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.69
PB Ratio	5.48
P/TBV Ratio	5.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.02
EV / Sales	3.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-27.70

Financial Position

The company has a current ratio of 17.92

Current Ratio	17.92
Quick Ratio	15.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.10% and return on invested capital (ROIC) is -26.61%.

Return on Equity (ROE)	-86.10%
Return on Assets (ROA)	-23.12%
Return on Invested Capital (ROIC)	-26.61%
Return on Capital Employed (ROCE)	-62.26%
Weighted Average Cost of Capital (WACC)	5.28%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.88
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.27% in the last 52 weeks. The beta is 0.19, so Avricore Health's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+27.27%
50-Day Moving Average	0.06
200-Day Moving Average	0.06
Relative Strength Index (RSI)	51.14
Average Volume (20 Days)	97,618

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Avricore Health had revenue of CAD 1.92 million and -1.63 million in losses. Loss per share was -0.02.

Revenue	1.92M
Gross Profit	835,532
Operating Income	-805,239
Pretax Income	-1.63M
Net Income	-1.63M
EBITDA	-578,027
EBIT	-805,239
Loss Per Share	-0.02

Balance Sheet

The company has 541,752 in cash and n/a in debt, with a net cash position of 541,752 or 0.01 per share.

Cash & Cash Equivalents	541,752
Total Debt	n/a
Net Cash	541,752
Net Cash Per Share	0.01
Equity (Book Value)	1.29M
Book Value Per Share	0.01
Working Capital	607,285

Cash Flow

In the last 12 months, operating cash flow was -146,707 and capital expenditures -89,686, giving a free cash flow of -236,393.

Operating Cash Flow	-146,707
Capital Expenditures	-89,686
Free Cash Flow	-236,393
FCF Per Share	-0.00

Margins

Gross margin is 43.48%, with operating and profit margins of -41.91% and -84.73%.

Gross Margin	43.48%
Operating Margin	-41.91%
Pretax Margin	-84.73%
Profit Margin	-84.73%
EBITDA Margin	-30.08%
EBIT Margin	-41.91%
FCF Margin	n/a

Dividends & Yields

Avricore Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.09%
Shareholder Yield	2.09%
Earnings Yield	-22.96%
FCF Yield	-3.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.25.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	0.25

Scores

Avricore Health has an Altman Z-Score of 89.42 and a Piotroski F-Score of 3.

Altman Z-Score	89.42
Piotroski F-Score	3